Informatie voor zorgprofessionals
Medische Oncologie
Tumortypes
Gastro-enterologische tumoren
Galblaas en galwegcarcinoom
Behandelmogelijkheden
Adjuvante behandeling
Geen adjuvante behandeling op basis van CieBOM advies (Primrose 2019).
Literatuur
- Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. The Lancet Oncology. 2019;20(5):663-73.
- Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. The New England journal of medicine. 2010;362(14):1273-81.
- Lamarca A, Palmer DH, Wasan HS, et al; Advanced Biliary Cancer Working Group. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC 06): a phase 3, open-label, randomised, controlled trial. Lancet Oncol 2021;22(5):690-701.